You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK — Early cancer detection firm Grail said last week that it will introduce its Galleri blood-based multi-cancer screening test in the UK next year through a partnership with the country's National Health Service (NHS).
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.
The emergence of cell clones that are resistant to targeted therapies poses a significant issue in the treatment of metastatic melanoma.